REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotek OOO (Moscow) (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biotek OOO Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

Biotec Company is one of Russian leading distributors and largest holding companies, specializing in manufacturing, wholesale and retail distribution of pharmaceutical products, as well as dealing with the scientific and practical researches in the field of modern medicines. The Corporation is involved in providing the therapeutic process in almost all regions of the Russian Federation. The company consists of 4 production, 6 offices, 19 subsidiaries, 361 pharmacies.

Headquarters
Lineinyi, 8, Pomeshtenie 1 Etazh 1; Komnaty 1-7
Moscow; Moscow; Postal Code: 127238

Contact Details: Purchase the Biotek OOO (Moscow) report to view the information.

Website: http://www.biotec.ru

Basic Information
Total Employees:
Purchase the Biotek OOO (Moscow) report to view the information.
Outstanding Shares:
Purchase the Biotek OOO (Moscow) report to view the information.
Registered Capital:
Purchase the Biotek OOO (Moscow) report to view the information.
Incorporation Date:
February 14, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
23%
Subsidiaries
Apteka №135
100%
Astrakhan-Farm
100%
BIOFARM
100%
Company Performance
Financial values in the chart are available after Biotek OOO (Moscow) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-94.24%
Total operating revenue
-94.24%
Operating profit (EBIT)
81.37%
Net Profit (Loss) for the Period
1.93%
Total assets
-58.03%
Total equity
N/A
Operating Profit Margin (ROS)
-28.42%
Net Profit Margin
-197.68%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
-0.46%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?